Immunocore Holdings plc American Depositary Shares Share Price
NASDAQ: IMCR | Small CapImmunocore Holdings plc American Depositary Shares Stock Performance
Open $34.50 | Prev. Close $34.52 | Circuit Range N/A |
Day Range $33.26 - $34.50 | Year Range $27.59 - $40.40 | Volume 21,366 |
Average Traded $33.67 |
Immunocore Holdings plc American Depositary Shares Share Price Today
As of 10 August 2026, Immunocore Holdings plc American Depositary Shares's share price is $34.01. The stock opened at $34.50, compared to its previous close of $34.52. During today's trading session, Immunocore Holdings plc American Depositary Shares's share price traded between $33.26 and $34.50, with an average price of $33.88. Over the past 52 weeks, the stock has recorded a high of $40.40 and a low of $27.59. In terms of performance, Immunocore Holdings plc American Depositary Shares's share price has risen by 5.16% over the last six months and is up 5.69% on a year-on-year basis.
Immunocore Holdings plc American Depositary Shares Share Price Chart
Immunocore Holdings plc American Depositary Shares Stock Fundamentals & Key Indicators
Market Cap $1.71B | PE Ratio (TTM) -47.90 | Dividend Yield N/A |
EPS (TTM) $-0.71 | Revenue (TTM) $400.02M | Return On Equity (TTM) -9.32% |
Profit Margin -8.88% | Debt to Equity 0.65 | Quarterly Earnings Growth YoY -102.03% |
Immunocore Holdings plc American Depositary Shares Quarterly Profit & Loss
All figures in USD
Immunocore Holdings plc American Depositary Shares Annual Profit & Loss
All figures in USD
About Immunocore Holdings plc American Depositary Shares
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 3 clinical trial to treat advanced cutaneous melanoma and adjuvant uveal melanoma; and brenetafusp that is in Phase 3 clinical trial to treat first-line advanced cutaneous melanoma and in a Phase 1/2 clinical trial in multiple tumor types. In addition, the company's products under development include IMC-R117C (PIWIL-1) that is in Phase 1/2 clinical trial for the treatment of advanced solid tumors, including colorectal cancer; IMC-P115C (PRAME-HLE-A02) that is in Phase 1 clinical trial for patients with tumors that express PRAME; IMC-M113V that is in Phase 1 clinical trials for a potential functional cure in human immunodeficiency virus (HIV); and IMC-I109V that is in Phase 1 clinical trials for a potential functional cure in hepatitis B virus (HBV). Further, it develops IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-S118AI to treat type 1 diabetes; and IMC-U120AI to treat atopic dermatitis. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
Immunocore Holdings plc American Depositary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $33.91 | $34.02 | +0.67% |
Jul 2026 | $31.88 | $33.80 | +6.47% |
Jun 2026 | $28.29 | $31.74 | +10.09% |
May 2026 | $27.72 | $28.83 | +2.89% |
Apr 2026 | $31.02 | $28.02 | -7.00% |
Mar 2026 | $31.93 | $30.13 | -6.83% |
Feb 2026 | $32.29 | $32.34 | -0.64% |
Jan 2026 | $34.62 | $32.55 | -5.98% |
Dec 2025 | $39.00 | $34.62 | -12.02% |
Nov 2025 | $32.81 | $39.35 | +19.51% |
Oct 2025 | $36.25 | $32.92 | -9.22% |
Sep 2025 | $32.86 | $36.27 | +12.71% |
IMCR Share Price FAQs
What is Immunocore Holdings plc American Depositary Shares share price today?
What is the 52 week high and 52 week low of Immunocore Holdings plc American Depositary Shares stock?
What is IMCR's market capitalisation today?
What is IMCR's net income for the last quarter?
What is the 5 year returns of IMCR?
What is the high & low stock price of IMCR today?
Can I buy IMCR shares in India?